Article
A20 is an immune tolerance factor that can determine islet transplant outcomes
2019-09-16
Abstract excerpt
Islet transplantation can restore lost glycemic control in type 1 diabetes subjects, but is restricted in its clinical application by limiting supplies of islets and the need for heavy immune suppression to prevent rejection. TNFAIP3 , encoding the ubiquitin editing enzyme A20, regulates the activation of immune cells by raising NF-κB signalling thresholds. Here we show that increasing A20 expression in allogenei...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 86a78189-72df-5677-b75d-dcbd5bae0198
- DOI
- 10.1101/770834
